BioMarin Pharmaceutical Q2 Earnings Call Highlights
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Thu, 6 August 2026
What it is about
Cristin HubbardAlexander HardyGreg FribergBrian MuellerBiomarin Pharmaceutical IncUnited StatesCalifornia, United States
Who published it, and when
How it spread - 1 original report
Thu, 6 August 2026
1 report- dailypolitical.com16:04first to report
BioMarin Pharmaceutical (NASDAQ:BMRN) reported second-quarter 2026 revenue of nearly $1 billion, up 20% from a year earlier, as growth across its rare-disease portfolio and the recently completed Amicus acquisition supported results. The company raised its full-year revenue, VOXZOGO revenue and non-GAAP diluted earnings-per-share guidance, though it did not provide updated ranges during the call. Chief […]